Aytu BioPharma Inc (AYTU)
2.62
-0.10
(-3.50%)
USD |
NASDAQ |
Apr 24, 13:07
Aytu BioPharma Market Cap: 14.59M for April 24, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 23, 2024 | 15.12M |
| April 22, 2024 | 15.64M |
| April 19, 2024 | 15.53M |
| April 18, 2024 | 15.53M |
| April 17, 2024 | 16.00M |
| April 16, 2024 | 15.92M |
| April 15, 2024 | 14.92M |
| April 12, 2024 | 16.09M |
| April 11, 2024 | 17.37M |
| April 10, 2024 | 17.91M |
| April 09, 2024 | 18.71M |
| April 08, 2024 | 18.37M |
| April 05, 2024 | 17.93M |
| April 04, 2024 | 17.82M |
| April 03, 2024 | 17.43M |
| April 02, 2024 | 16.87M |
| April 01, 2024 | 16.65M |
| March 28, 2024 | 16.93M |
| March 27, 2024 | 17.15M |
| March 26, 2024 | 17.15M |
| March 25, 2024 | 17.01M |
| March 22, 2024 | 16.93M |
| March 21, 2024 | 16.59M |
| March 20, 2024 | 16.09M |
| March 19, 2024 | 15.92M |
| Date | Value |
|---|---|
| March 18, 2024 | 16.09M |
| March 15, 2024 | 15.98M |
| March 14, 2024 | 15.98M |
| March 13, 2024 | 16.98M |
| March 12, 2024 | 17.54M |
| March 11, 2024 | 17.54M |
| March 08, 2024 | 17.48M |
| March 07, 2024 | 17.12M |
| March 06, 2024 | 16.68M |
| March 05, 2024 | 16.93M |
| March 04, 2024 | 16.42M |
| March 01, 2024 | 16.48M |
| February 29, 2024 | 16.09M |
| February 28, 2024 | 16.48M |
| February 27, 2024 | 15.81M |
| February 26, 2024 | 16.09M |
| February 23, 2024 | 16.31M |
| February 22, 2024 | 16.48M |
| February 21, 2024 | 16.76M |
| February 20, 2024 | 18.26M |
| February 16, 2024 | 17.65M |
| February 15, 2024 | 17.37M |
| February 14, 2024 | 17.54M |
| February 13, 2024 | 16.65M |
| February 12, 2024 | 16.31M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
5.783M
Minimum
May 05 2023
227.00M
Maximum
Mar 19 2021
58.97M
Average
24.38M
Median
Aug 02 2019
Market Cap Benchmarks
| Regen BioPharma Inc | 2.850M |
| Clearday Inc | 15.70M |
| Bioxytran Inc | 20.38M |
| Shuttle Pharmaceuticals Holdings Inc | 6.500M |
| CEL-SCI Corp | 78.81M |
Market Cap Related Metrics
| PS Ratio | 0.1250 |
| Price to Book Value | 0.4440 |
| Price to Free Cash Flow | 2.013 |
| Price | 2.62 |
| Earnings Yield | -154.2% |